# Stanford Researchers Find Sea Squirt Compound Reverses Aging Signs in Mice
Stanford scientists have identified a natural compound in edible sea squirts that reversed multiple aging markers in older mice, according to research published through ScienceDaily. The substance, plasmalogen, produced measurable improvements in memory, learning capacity, neural connectivity, inflammation levels, and even hair thickness and pigmentation.
Sea squirts, also called ascidians, are marine filter feeders consumed as food in parts of Asia and the Mediterranean. Researchers extracted plasmalogens, a class of phospholipids found abundantly in sea squirt tissues, and administered them as supplements to aging mice. The results demonstrated that these compounds worked across multiple biological systems simultaneously.
The cognitive benefits proved most striking. Older mice receiving plasmalogen supplements showed enhanced memory retention and faster learning in behavioral tests compared to untreated controls. More fundamentally, researchers observed strengthened synaptic connections between neurons, the physical basis of these cognitive improvements. Brain imaging and cellular analysis revealed that plasmalogens appeared to stabilize and reinforce the connections neurons use to communicate.
The compound also reduced neuroinflammation, a hallmark of aging brains. Chronic inflammation accelerates cognitive decline and contributes to neurodegenerative diseases. By lowering inflammatory markers in brain tissue, plasmalogen supplements addressed a root cause of age-related mental decline. Simultaneously, the mice exhibited thicker, darker hair growth, suggesting systemic effects beyond the nervous system.
Researchers believe plasmalogens work by encouraging brain regeneration at the cellular level and protecting vulnerable synapses from age-related deterioration. Plasmalogens comprise nearly 20 percent of phospholipids in the mammalian brain but decline with age. This natural depletion may contribute to cognitive decline and neurological aging. Replenishing plasmalogen levels through supplementation appears to reverse this process, at least in laboratory settings.
The Stanford team did not publish the full peer-reviewed study details in the available reporting, making independent verification of specific results impossible at present. Animal studies frequently fail to translate to human efficacy, a persistent limitation in aging research. Mice metabolize compounds differently than humans, and controlled laboratory conditions rarely mirror real-world complexity. Dosing, duration, and long-term safety in humans remain unknown.
The findings nonetheless open a plausible research pathway. Plasmalogens naturally occur in multiple dietary sources beyond sea squirts, including fish, eggs, and some organ meats. If human trials confirm even partial benefits seen in mice, dietary approaches or targeted supplements could offer accessible interventions for age-related cognitive decline. The global aging population faces rising rates of dementia and Alzheimer's disease, creating urgent demand for effective preventive treatments.
Next steps require human clinical trials to test whether plasmalogen supplementation produces comparable results in aging human brains. Researchers will need to determine optimal dosing, identify which populations benefit most, and confirm safety across diverse populations. The Stanford team's mouse model provides a foundation, but substantial additional work separates promising laboratory results from viable clinical therapies.